Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

NOI; non-competitive combined synopsis solicitatio

Active
75N98026Q01209Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(1)

75N98026Q01209/PCA-NIA-08501 - Murine DNA Methylation Array Processing

PDFrfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseCombined Synopsis
Posted

Combined Synopsis

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q01209/PCA-NIA-08501. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Epigenetic Clock Development Foundation 1124 W. Carson Street, MRL Bldg., 3rd Floor Torrance, CA 90502 US to provide obtain DNA methylation profiling and epigenetic age analysis for 320 previously extracted murine DNA samples using the Mammal320K methylation array and established Horvath epigenetic clock methodologies.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
Solicitation # 75N98026R00085
The National Institutes of Health Office of the Director intends to award a firm-fixed-price purchase order to the University of Illinois at Chicago for preclinical animal research services. The project focuses on evaluating the therapeutic effects of soluble adenylyl cyclase inhibition on pulmonary arterial hypertension using an established endothelial cell-specific Cav1 knockout murine model and wild-type controls. The government is pursuing a sole-source acquisition under FAR 13.106-1(b)(1) because the University of Illinois at Chicago maintains the specific mouse colony required for the study, which is not known to be available from other laboratories. The scope of work involves 144 animals subjected to normoxia or chronic hypoxia and treated with sAC inhibitors KH7 or LRE1, both of which will be provided by the government. Required services include animal breeding, colony maintenance, genotyping, implantation of subcutaneous osmotic pumps, echocardiography, and right-heart catheterization. The contractor will also be responsible for necropsy and the preparation of lung and heart tissue for histological analysis, Western blotting, and RNA-seq. The anticipated period of performance is 12 months from the date of award, and the total value is not expected to exceed the simplified acquisition threshold. While the government intends to negotiate with a single source, responsible parties may submit capability statements and quotations by September 21, 2026.
National Institute Of Health Nih-Od

POSTED

about 8 hours ago

DEADLINE

in 7 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS